Hadas Shiran

Cardiologist

Instructor, Medicine - Cardiovascular Medicine

Center for Marfan Syndrome and Related Aortic Disorders

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-725-8246
Learn More About the Clinic Getting Here Make An Appointment

Aortic Disease Center

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6459
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: University of Michigan Medical Center (06/2008) MI

Fellowship: Stanford University (06/2011) CA

Fellowship: Stanford University (06/2013) CA

Board Certification: Echocardiography, National Board of Echocardiography (2013)

Medical Education: Dartmouth Medical School (06/2005) NH

Board Certification: Cardiovascular Disease, American Board of Internal Medicine (2012)

Board Certification: Internal Medicine, American Board of Internal Medicine (2008)

Fellow, Stanford University School of Medicine, Multimodality Cardiovascular Imaging (2013)

Fellow, Stanford University School of Medicine, Cardiovascular MRI (2013)

Fellow, Stanford University School of Medicine, Cardiovascular Medicine (2011)

Resident, University of Michigan Hospitals, Internal Medicine Training Program (2008)

Intern, University of Michigan Hospitals, Internal Medicine Training Program (2006)

MD, Dartmouth Medical School, Medicine (2005)

BS, University of California, Berkeley, Bioengineering, chemical engineering (2000)

Honors & Awards

Women in Cardiology Trainee Award for Excellence, American Heart Association (2010)

Dean’s Fellowship Award, Stanford University (2010)

Alderman Award for Excellence in Clinical Research, Stanford University (2011)

Early Investigator Grant Program Award Recipient, The Marfan Foundation (2014-2015)

Scientist Development Grant Recipient, American Heart Association (2014-2017)

Relationship between Echocardiographic and Magnetic Resonance Derived Measures of Right Ventricular Size and Function in Patients with Pulmonary Hypertension
Shiran, H., Zamanian, R. T., McConnell, M. V., Liang, D. H., Dash, R., & Yang, P. C. (2014). Relationship between Echocardiographic and Magnetic Resonance Derived Measures of Right Ventricular Size and Function in Patients with Pulmonary Hypertension. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 27(4), 405-412.

Unexplained double-chambered left ventricle associated with contracting right ventricular aneurysm and right atrial enlargement.
Finocchiaro, G., Murphy, D., Pavlovic, A., Haddad, F., Shiran, H., & Knowles, J. W. (2014). Unexplained double-chambered left ventricle associated with contracting right ventricular aneurysm and right atrial enlargement. Echocardiography (Mount Kisco, N.Y.), 31(3), E80-4.

Comparison of Aortic Root Diameter to Left Ventricular Outflow Diameter Versus Body Surface Area in Patients With Marfan Syndrome
Shiran, H., Haddad, F., Miller, D. C., & Liang, D. (2012). Comparison of Aortic Root Diameter to Left Ventricular Outflow Diameter Versus Body Surface Area in Patients With Marfan Syndrome. AMERICAN JOURNAL OF CARDIOLOGY, 110(10), 1518-1522.

Correlates of Delayed Recognition and Treatment of Acute Type A Aortic Dissection The International Registry of Acute Aortic Dissection (IRAD)
Harris, K. M., Strauss, C. E., Eagle, K. A., Hirsch, A. T., Isselbacher, E. M., & Nienaber, C. A. (2011). Correlates of Delayed Recognition and Treatment of Acute Type A Aortic Dissection The International Registry of Acute Aortic Dissection (IRAD). CIRCULATION, 124(18), 1911-U82.

Humanitarian use devices/humanitarian device exemptions in cardiovascular medicine
Kaplan, A. V., Harvey, E. D., Kuntz, R. E., Shiran, H., Robb, J. F., & Fitzgerald, P. (2005). Humanitarian use devices/humanitarian device exemptions in cardiovascular medicine. CIRCULATION, 112(18), 2883-2886.

A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis
Yao, X. M., Hu, J. F., Daniels, M., Yien, H. F., Lu, H. Q., & Hoffman, A. R. (2003). A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis. CLINICAL CANCER RESEARCH, 9(7), 2719-2726.

A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma
Yao, X. M., Hu, J. F., Daniels, M., Shiran, H., Zhou, X. J., & Hoffman, A. R. (2003). A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. JOURNAL OF CLINICAL INVESTIGATION, 111(2), 265-273.